| Not quite... From the article - "The testing I signed up for is needed to win U.S. Food and Drug Administration approval." Powered exoskeletons for spinal cord injury or paralysis patients are medical devices, and thus require FDA approval (in this case, Berkeley Bionics is probably pursuing a 510(k) or the 'de novo' process if B.B feels their device is substantially different from pre-existing exoskeletons.) All current exoskeletons are classified as type II medical devices, which entails some limitations on how they can be marketed, sold, and used by patients. Since their other products are not used for medical applications, they wouldn't need FDA approval, as long as B.B isn't, say, making health related claims that would need to be substantiated by actual testing and certification (I believe). I actually work in this field, so if you have any other questions about exoskeletons or assistance devices I can probably answer them. |
This seems to be a case where regulation is slowing innovation. And I don’t say that very often...